STERIS Basic EPS 2010-2025 | STE
STERIS annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- STERIS basic eps for the quarter ending June 30, 2025 was $1.80, a 22.45% increase year-over-year.
- STERIS basic eps for the twelve months ending June 30, 2025 was $6.57, a 62.22% increase year-over-year.
- STERIS annual basic eps for 2025 was $0.006B, a 62.92% increase from 2024.
- STERIS annual basic eps for 2024 was $0.004B, a 257.94% increase from 2023.
- STERIS annual basic eps for 2023 was $0.001B, a 57.2% decline from 2022.
| STERIS Annual Basic EPS | |
|---|---|
| 2025 | $6.24 |
| 2024 | $3.83 |
| 2023 | $1.07 |
| 2022 | $2.50 |
| 2021 | $4.66 |
| 2020 | $4.81 |
| 2019 | $3.59 |
| 2018 | $3.42 |
| 2017 | $1.29 |
| 2016 | $1.57 |
| 2015 | $2.27 |
| 2014 | $2.20 |
| 2013 | $2.74 |
| 2012 | $2.33 |
| 2011 | $0.86 |
| 2010 | $2.18 |
| 2009 | $1.88 |
| STERIS Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $1.80 |
| 2025-03-31 | $1.49 |
| 2024-12-31 | $1.76 |
| 2024-09-30 | $1.52 |
| 2024-06-30 | $1.47 |
| 2024-03-31 | $-0.01 |
| 2023-12-31 | $1.42 |
| 2023-09-30 | $1.17 |
| 2023-06-30 | $1.25 |
| 2023-03-31 | $1.87 |
| 2022-12-31 | $1.24 |
| 2022-09-30 | $-3.15 |
| 2022-06-30 | $1.11 |
| 2022-03-31 | $0.60 |
| 2021-12-31 | $1.44 |
| 2021-09-30 | $0.70 |
| 2021-06-30 | $-0.24 |
| 2021-03-31 | $1.03 |
| 2020-12-31 | $1.34 |
| 2020-09-30 | $1.24 |
| 2020-06-30 | $1.05 |
| 2020-03-31 | $1.45 |
| 2019-12-31 | $1.24 |
| 2019-09-30 | $1.12 |
| 2019-06-30 | $1.00 |
| 2019-03-31 | $1.27 |
| 2018-12-31 | $0.57 |
| 2018-09-30 | $0.92 |
| 2018-06-30 | $0.83 |
| 2018-03-31 | $0.86 |
| 2017-12-31 | $1.12 |
| 2017-09-30 | $0.76 |
| 2017-06-30 | $0.68 |
| 2017-03-31 | $0.32 |
| 2016-12-31 | $-0.06 |
| 2016-09-30 | $0.47 |
| 2016-06-30 | $0.56 |
| 2016-03-31 | $0.75 |
| 2015-12-31 | $0.26 |
| 2015-09-30 | $0.15 |
| 2015-06-30 | $0.41 |
| 2015-03-31 | $0.70 |
| 2014-12-31 | $0.64 |
| 2014-09-30 | $0.52 |
| 2014-06-30 | $0.41 |
| 2014-03-31 | $0.67 |
| 2013-12-31 | $0.48 |
| 2013-09-30 | $0.50 |
| 2013-06-30 | $0.55 |
| 2013-03-31 | $0.71 |
| 2012-12-31 | $0.82 |
| 2012-09-30 | $0.69 |
| 2012-06-30 | $0.52 |
| 2012-03-31 | $0.77 |
| 2011-12-31 | $0.58 |
| 2011-09-30 | $0.50 |
| 2011-06-30 | $0.48 |
| 2011-03-31 | $0.65 |
| 2010-12-31 | $0.37 |
| 2010-09-30 | $0.60 |
| 2010-06-30 | $-0.76 |
| 2010-03-31 | $0.49 |
| 2009-12-31 | $0.70 |
| 2009-09-30 | $0.55 |
| 2009-06-30 | $0.44 |
| 2009-03-31 | $0.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.473B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $185.313B | 22.42 |
| Intuitive Surgical (ISRG) | United States | $167.925B | 69.61 |
| IDEXX Laboratories (IDXX) | United States | $51.311B | 53.40 |
| Edwards Lifesciences (EW) | United States | $47.473B | 31.46 |
| Alcon (ALC) | Switzerland | $39.834B | 26.74 |
| IQVIA Holdings (IQV) | United States | $31.963B | 18.06 |
| DexCom (DXCM) | United States | $29.788B | 44.68 |
| Mettler-Toledo (MTD) | United States | $26.568B | 31.53 |
| Waters (WAT) | United States | $17.795B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.026B | 0.00 |
| Hologic (HOLX) | United States | $14.931B | 16.18 |
| Penumbra (PEN) | United States | $10.302B | 75.26 |
| Globus Medical (GMED) | United States | $8.290B | 19.12 |
| Sysmex ADR (SSMXY) | Japan | $8.139B | 25.86 |
| Masimo (MASI) | United States | $7.885B | 26.54 |
| Teleflex (TFX) | United States | $5.637B | 9.10 |
| Glaukos (GKOS) | United States | $5.250B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.57 |
| Integer Holdings (ITGR) | United States | $3.811B | 19.02 |
| LivaNova (LIVN) | United Kingdom | $3.077B | 17.61 |
| Alphatec Holdings (ATEC) | United States | $2.344B | 0.00 |
| Veracyte (VCYT) | United States | $2.325B | 32.12 |
| PROCEPT BioRobotics (PRCT) | United States | $2.187B | 0.00 |
| Artivion (AORT) | United States | $2.056B | 103.74 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.866B | 17.46 |
| Integra LifeSciences Holdings (IART) | United States | $1.112B | 6.37 |
| Pulse Biosciences (PLSE) | United States | $1.109B | 0.00 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.909B | 44.14 |
| Tandem Diabetes Care (TNDM) | United States | $0.818B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.692B | 0.00 |
| AxoGen (AXGN) | United States | $0.681B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.538B | 9.51 |
| OrthoPediatrics (KIDS) | United States | $0.509B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.472B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.444B | 3.57 |
| Pacific Biosciences Of California (PACB) | United States | $0.396B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.08 |
| AngioDynamics (ANGO) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.75 |
| RxSight (RXST) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.290B | 20.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.272B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.219B | 0.00 |
| Neuronetics (STIM) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.133B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| InspireMD (NSPR) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.085B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.38 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |